Skip to main content
SpringerLink
Log in

Pediatric Psychopharmacological and Combined Interventions

  • Chapter
Child Neuropsychology

  • 157k Accesses

Abstract

Some pediatric disorders with biogenetic or neuropsychological causes may require medical treatments (Wilens, 2001). Most of these disorders, however, require multimodal treatments, where medication is used in combination with other psychosocial and behavioral interventions or therapies. A select list of common medications will be reviewed, including those designed to control ADHD, major depressive disorders, bipolar disorders, psychotic disorders, Tourette syndrome, and seizure disorders. The National Institute of Mental Health (NIMH) has funded a number of studies to investigate the safety and efficacy of medications and psychosocial interventions for common childhood and adolescent disorders. These will be briefly reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abikoff, M., Hechtman, L., Klein, R., Weiss, K., Fleiss, K., Etcovitch, J., et al. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802–811.

    Article  Google Scholar 

  • Balthazor, M. J., Wagner, R. K., & Pelham, W. E. (1991). The specificity of the effects of stimulant medications on classroom-learning related measures of cognitive processing for attention deficit disorder children. Journal of Abnormal Child Psychology, 19, 35–52.

    Article  Google Scholar 

  • Barkley, R. A., (2006). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed.). New York: Guilford Press.

    Google Scholar 

  • Barkley, R. A., Anderson, D. L., & Kruesi, M. (2007). A pilot study of the effects of Atomexetine on driving in adults with ADHD. Journal of Attention Disorders, 10, 306–316.

    Article  Google Scholar 

  • Barkley, R. A., & Cunningham, C. E. (1979). Stimulant drugs and activity level in hyperactive children. American Journal of Orthopsychiatry, 49,491–499.

    Article  Google Scholar 

  • Barkley, R. A., & Cunningham, C. E. (1980). The parent-child interactions of hyperactive children and their modification by stimulant drugs. In R. Knights & D. Bakker (Eds.), Treatment of hyperactive and learning disabled children (pp. 219–236). Baltimore, MD: University Park Press.

    Google Scholar 

  • Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1991). Attention deficit disorder with and without hyperactivity: Clinical response to three doses of methylphenidate. Pediatrics, 87, 519–531.

    PubMed  Google Scholar 

  • Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2006). Young adult outcome of hyperactive children: Adaptive functioning in major life activities. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 192–202.

    Article  Google Scholar 

  • Barkley, R. A., Murphy, K. R., & Fischer, M. (2008). ADHD in adults: What the science says. New York: Guilford Press.

    Google Scholar 

  • Bhatia, S. K., Rezac, A. J., Vitiello, B., Sitorius, M. A., Buehler, B. A. & Kratochvil, C. J. (2008). Antidepressant prescribing practices for the treatment of children and adolescents. Journal of Child and Adolescent Psychopharmacology, 18(1), 70–80.

    Article  Google Scholar 

  • Biederman, J., Faraone, S., Monuteaux, M., & Grossbard, J. (2004). How informative are parent reports of ADHD symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents’ and teachers’ reports. Pediatrics, 113(6), 1667–1671.

    Article  Google Scholar 

  • Birmaher, B. (1998). Should we use antidepressant medications for children and adolescents with depression? Psychopharmacology Bulletin, 34, 245–251.

    Google Scholar 

  • Birmaher, B., & Brent, D. A. (2003). Antidepressants: II: Tricylic agents. In A. Martin, L. Scahill, D. S. Chaney, & J. F. Leckman (Eds.), Pediatric psychopharmacology: Principles and practice (pp. 466–483). New York: Oxford University Press.

    Google Scholar 

  • Bohnstedt, B. N., Kronenberger, W. G., Dunn, D. W., Giaugue, A. L., Wood, E. A., Rembusch, M. E., et al. (2005). Investigator ratings of ADHD symptoms during a randomized trial of Atomoxetine: A comparison of parents and teachers as informants. Journal of Attention Disorders, 8(4), 153–159.

    Article  Google Scholar 

  • Bostic, J. Q., Prince, J., Frazier, J., DeJong, S., & Wilens, T. E. (2003). Pediatric psychopharmacology update. Psychiatric Times, 20, 9.

    Google Scholar 

  • Brent, D., Emslie, G., Clarke, G., Wagner, K., Asarnow, J., Keller, M., et al. (2008). Switching to another SSRI or to Venlafaxine with and without cognitive behavioral therapy for adolescents with SSRI-resistant depression. JAMA, 299(8), 901–913.

    Article  Google Scholar 

  • Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297(15), 1683–1696.

    Article  Google Scholar 

  • Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, M. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom behavior, academic performance, and self-evaluations of children with attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology, 202, 213–232.

    Article  Google Scholar 

  • Comings, D. E. (1990). Tourette syndrome and human behavior. Durante, CA; Hope Press.

    Google Scholar 

  • Connor, D. F. (2006). Stimulants. In R.A. Barkley, Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed., pp. 608–647). New York: Guilford Press.

    Google Scholar 

  • Corkum, P., Panton, R., Ironside, S., MacPherson, M., & Williams, T. (2008). Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. Journal of Pediatric Psychology, 33(4), 368–379.

    Article  Google Scholar 

  • Doehring, D. G. (1968). Patterns of impairment in specific reading disability: A neuropsychological investigation. Bloomington: Indiana University Press.

    Google Scholar 

  • Dubovsky, S. L. (1992). Psychopharmacological treatment in neuropsychiatry. In S. C. Yudofsky & R. E. Hales (Eds.), The American Psychiatric Press textbook of neuropsychiatry (2nd ed., pp. 663–702). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • DuPaul, G., & Stoner, Ga. (2003). ADHD in the schools: Assessment and intervention strategies (2nd ed.). New York: Guilford Press.

    Google Scholar 

  • DuPaul, G., Barkley, R. A., & McMurphy, M. B. (1991). Therapeutic effects of medication on ADHD: Implications for school psychologists. School Psychology Review, 20,203–219.

    Google Scholar 

  • DuPaul, G. J., McGoey, K. E., & Mautone, J. A. (2003). Pediatric pharmacology and psychopharmacology. In M. C. Roberts (Ed.), Handbook of pediatric psychology (3rd ed. pp. 234–252). New York: Guilford Press.

    Google Scholar 

  • Faraone, S. V., Wigal, S. B., & Hodgins, P. (2007). Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and Atomoxetine (Stratttera) in school-aged children with ADHD. Journal of Attention Disorders, 11(1), 74–82.

    Article  Google Scholar 

  • Gadow, K. D., & Poling, A. G. (1988). Pharmacotherapy and mental retardation. Boston: College Hill Press.

    Google Scholar 

  • Ghuman, J. K., Riddle, M. A., Vitiello, B., Greenhill, L. L., Ghuang, S., Wigal, S. et al. (2007). Comorbidity moderates response to methylphenidate in the preschoolers with attention deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(5), 563–580.

    Article  Google Scholar 

  • Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J.J. (2006). The relationship between antidepressant prescription rates and rate of early adolescent suicide. American Journal of Psychiatry 163, 1898–1904.

    Article  Google Scholar 

  • Green, W. H. (1991). Child and adolescent clinical psychopharmacology. Baltimore, MD: Williams & Wilkins.

    Google Scholar 

  • Greenhill, L., Kollins, S., Abikoff, H., McCracken, J., Riddle, M., Swanson, J., et al. (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. 45(11), 1284–1293.

    Article  Google Scholar 

  • Handen, B. L., & Gilchrist, R. (2006). Practitioner review: Psychopharmacology in children with mental retardation. Journal of Child Psychology and Psychiatry, 47(9), 871–882.

    Article  Google Scholar 

  • Hasler, G., Fromm, S., Carlson, P. J., Luckenbaugh, D. A., Waldeck ,T., Geraci, M.,et al. (2008). Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry, 65(5), 521–531.

    Article  Google Scholar 

  • Hinshaw, S. P. (1991). Stimulant medication and the treatment of aggression in children with attention deficits. Journal of Clinical Child Psychology, 20, 301–312.

    Article  Google Scholar 

  • Hinshaw, S. P., Henker, B., Whalen, C. K., Erhardt, D., & Dunnington, R. E. (1989). Aggressive, prosocial, and nonsocial behavior in hyperactive boys: Dose effects of methylphenidate in naturalistic settings. Journal of Consulting and Clinical Psychology, 57, 636–443.

    Article  Google Scholar 

  • Hunt, R. D., Mandl, L., Lau, S., & Hughes, M. (1991). Neurobiological theories of ADHD and Ritalin. In L. Greenhill (Ed.), Ritalin theory and practice (pp. 267–287). New York: Mary Ann Leibert Press

    Google Scholar 

  • Jacobvitz, D., Sroufe, L. A., Stewart, M., & Leffert, N. (1990). Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. Journal of the American Academy of Child & Adolescent Psychiatry. 29(5), 677–688.

    Article  Google Scholar 

  • Joshi, P. T., Cappozzoli, J. A., & Coyle, J. T. (1988). Low-dose neuroleptic therapy for children with child-onset pervasive developmental disorder. American Journal of Psychiatry, 145,335–338.

    Article  Google Scholar 

  • Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., et al. (2004). Once-daily Atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo controlled trial. Pediatrics, 114 (1), e1–e8.

    Article  Google Scholar 

  • Kratochvil, C., Heiligenstein, J., Dittmann, R., Spencer, T. J., Biederman, J., Wernicke, J., et al. (2002). Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial. Journal of the American Academy of Child & Adolescent Psychiatry. 41(7), 776–784.

    Article  Google Scholar 

  • McGough, J. J., Wigal, S., Abikoff, H., Turnbow, J. M., Posner, K., & Moon, E. (2006). A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. Journal of Attention Disorders, 9(3), 476–485.

    Article  Google Scholar 

  • MTA Cooperative Group. (2004a). National Institute of Mental Health Multimodal Treatment Study of Attention-deficit/hyperactivity disorder. Pediatrics, 113, 754–761.

    Article  Google Scholar 

  • MTA Cooperative Group. (2004b). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762–769.

    Article  Google Scholar 

  • MTA Cooperative Group. (2008a). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with AD/HD (MTA): Part I: Executive summary. Journal of Attention Disorders, 12(1), 3–13.

    Article  Google Scholar 

  • MTA Cooperative Group. (2008b). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with AD/HD (MTA): Part II: Supporting details. Journal of Attention Disorders, 12(1), 14–41.

    Google Scholar 

  • MTA Research Symposium (2007, November). Key impact of the MTA study: What is the take-home message. Paper presented at the 20th Anniversary Hall of Fame Conference, CHADD. Crystal City, VA.

    Google Scholar 

  • Neppe, V. M., & Tucker, G. J. (1992). Neuropsychiatric aspects of seizure disorders. In S. C. Yudofsky & R. E. Hales (Eds.), The American Psychiatric Press textbook of neuropsychiatry (2nd ed., pp. 397–425). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • NIMH. (2007). Medications with Adendum January 2007. Department of Health and Human Services. National Institute of Health.

    Google Scholar 

  • Olfson M., Marcus S. C., & Shaffer D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults. Archives of General Psychiatry, 63, 865–872.

    Article  Google Scholar 

  • Pelham, W. E. (1993). Pharmacotherapy for children with attention deficit-hyperactivity disorder. School Psychology Review, 22, 1–227.

    Google Scholar 

  • Pelham, W. E., Schnedler, R, W., Bender, M. E., Nilsson, D. E., Miller, J., Budrow, M. S., et al. (1988). The combination of behavior therapy and methylphenidate in the treatment of attention deficit disorders. In L. Bloomingdale (Eds.), Attention deficit disorder (Vol. 3, pp. 29–48). New York: Pergamon Press.

    Google Scholar 

  • Pellock, J. M. (1987). Carbamazepine side effects in children and adults. Epilepsia, 28, S64–S70.

    Article  Google Scholar 

  • Phelps, L., Brown, R. T., & Power, T. J. (2002). Pediatric psychopharmacology: Combining medical and psychosocial interventions.NY: Guilford Press.

    Book  Google Scholar 

  • Pliszka, S. R. (2003). Neuroscience of mental health clinicians. New York: Guilford Press.

    Google Scholar 

  • Pliszka, S. R., Carlson, C. L., & Swanson, J. M. (1999). ADHD with comorbid disorders. New York: Guilford Press.

    Google Scholar 

  • Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., et al. (2004). Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25(1), 119–142.

    Article  Google Scholar 

  • Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A., Stewart, J. W., Warden, D., et al. (2006). Acute and longer-term outcomes in depressed outpatients who required one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917.

    Article  Google Scholar 

  • Salzman, C. (1990). Benzodiazepine dependency: Summary of the APA task force on benzodiapines. Psychopharmacology Bulletin, 26, 61–62.

    Google Scholar 

  • Safer, D. (2006). Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders? Pediatrics, 118(3), 1248–1251.

    Article  Google Scholar 

  • Schaughency, E. A., & Hynd, G. W. (1989). Attentional control systems and the attentional deficit disorders (ADD). Learning and Individual Differences, 4, 42–449.

    Google Scholar 

  • Scheffer, R. E., Kowatch, R. A., Carmody, T., & Rush, A. J. (2005). Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. American Journal of Psychiatry, 162(1):58–64.

    Article  Google Scholar 

  • Silva, R. R., Munoz, D. M., & Alpert, M. (1996). Carbamazepine use in children: Adolescents with features of attention-deficit hyperactivity disorders: A meta-analysis. The American Academy of Child and Adolescent Psychiatry, 35(3), 352–358.

    Article  Google Scholar 

  • Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. (2006). Suicide risk during antidepressant treatment. American Journal of Psychiatry, 163(1), 41–47.

    Article  Google Scholar 

  • Swanson, J., Greenhill, L. L., Wigal, T., Kollins, S., Stehli, A. M., Davies, M., et al. (2006). Stimulant-related reductions of growth rates in the PATS. Journal of Child and Adolescent Psychopharmacology, 45(11), 1304–1313.

    Article  Google Scholar 

  • Treatment for Adolescents with Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292(7):807–820.

    Article  Google Scholar 

  • Taylor, E. Anderson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Dopfner, M., et al. (2004). Clinical guidelines for hyperkinetic disorder. European Child and Adolescent Psychiatry, 13(Suppl. 1), 17–130.

    Google Scholar 

  • US Food & Drug Administration. (2004). Background on suicidality associated with antidepressant drug treatment. Retrieved from www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-04-Tab02-Laughren-Jan5.pdf

  • Vetter, V. L., Elia, J., Erickson, C., Berger, S., Nathan Blum, N., Uzark, K., et al. (2008). Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation; 117, 2407–2423.

    Google Scholar 

  • Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., et al. (2002). Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse, 43, 181–187.

    Article  Google Scholar 

  • Weissman, M. M., Pilowsky, D. J., Wickramaratne, P. J., Talati, A., Wisniewski, S. R., Fava, M., et al. (2006). Remission in maternal depression and child psychopathology: A STAR*D-Child report. JAMA, 295, 1389–1398.

    Article  Google Scholar 

  • Weizman, A., Weitz, R., Szekely, G. A., Tyana, S., & Belmaker, R. H. (1984). Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity. Journal of American Academy of Child Psychiatry, 23,295–298.

    Article  Google Scholar 

  • Wilens, T. E. (2001). Straight talk about psychiatric medications for kids. New York: Guilford Press.

    Google Scholar 

  • Wilens, T. E., & Spencer, T. J. (1999). Debate: Combining methylphenidate and clonidine: A clinically sound medication option. Journal of the Child and Adolescent Psychiatry, 38, 614–622.

    Article  Google Scholar 

  • Wilens, T. E., & Spencer, T. J. (2000). The stimulants revisited. Child and Adolescent Psychiatric Clinics of North America, 9(3), 573–603.

    PubMed  Google Scholar 

  • Wood, J. G., Crager, J. L., Delap, C. M., & Heiskell, K. D. (2007). Beyond methylphenidate: Nonstimulant medications for youths with ADHD. Journal of Attention Disorders, 11(3), 341–350.

    Article  Google Scholar 

  • Zametkin, A. J., & Liotta W. (1998). The neurobiology of attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 59(Suppl 7), 17–23.

    PubMed  Google Scholar 

  • Zametkin, A. J., & Rapoport, J. L. (1986). The pathophysiology of attention deficit disorder with hyperactivity. In B. B. Lahey & A. E. Kazdin (Eds.), Advances in clinical child psychology (Vol. 9, pp. 177–216). New York: Plenum Press.

    Chapter  Google Scholar 

  • Zametkin, A., & Rapoport, J. L. (1987). Noradrenergic hypothesis of attention deficit disorder with hyperactivity: A critical review. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 837–842). New York: Raven Press.

    Google Scholar 

  • Zametkin, A., Rapoport, J. L., Murphy, D. L., Linnoila, M., & Ismond, D. (1985). Treatment of hyperactive children with monamine oxidase inhibitors: I. Clinical efficacy. Archives of General Psychiatry, 42, 962–966.

    Article  Google Scholar 

  • Zisook, S., Lesser, I., Stewart, J. W., Wisniewski, S. R., Balasubramani, G. K., Fava, M., et al. (2007). Effect of age at onset on the course of major depressive disorder. American Journal of Psychiatry 164, 1539–1546.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michigan State University, 3123 S. Cambridge Road, Lansing, MI, 48911, USA

    Margaret Semrud-Clikeman

  2. Department of Educational Psychology, University of Wisconsin, 793 Enderis Hall, 2400 East Hartford Avenue, Milwaukee, WI, 53211, USA

    Phyllis Anne Teeter Ellison

Authors
  1. Margaret Semrud-Clikeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phyllis Anne Teeter Ellison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret Semrud-Clikeman .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Semrud-Clikeman, M., Ellison, P.A.T. (2009). Pediatric Psychopharmacological and Combined Interventions. In: Child Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88963-4_17

Download citation

Publish with us

Policies and ethics

Search

Navigation